🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

UPDATE 2-European stocks ends higher on vaccine cheer, M&A support

Published 2020/11/18, 12:00
Updated 2020/11/18, 19:24
© Reuters.

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

* Pfizer vaccine update supports risky assets

* Britain's RSA jumps on merger deal

* Deutsche Boerse gains after ISS deal

* STOXX 600 on course for best month on record (Updates to market close)

By Shashank Nayar and Sruthi Shankar

Nov 18 (Reuters) - European stocks closed higher on Wednesday as more positive updates on COVID-19 vaccine and merger activity in the region helped offset worries about the fast-spreading virus.

The pan-European STOXX 600 index .STOXX rose 0.4%, returning to a more than eight-month high hit earlier this week.

Economically sensitive stocks such as automakers .SXAP , banks .SX7P , miners .SXPP and retailers .SXRP rose more than 1%, leading sectoral gains.

After a sluggish start, European bourses got a boost from news that final results from Pfizer Inc (NYSE:PFE)'s PFE.N COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for it to apply for an emergency U.S. authorization. the market response was measured as investors expect any vaccine rollout to take time, while more U.S. and European restrictions in the absence of fresh stimulus could weigh on economic activity.

"If a vaccine were somehow to be available even by December, that would be great. But the impact is going to be very marginal," said Chris Beauchamp, chief market analyst at IG.

"Investors are aware that a vaccine will be here eventually and some (stimulus) needs to come in fairly soon to provide that bridge through the difficult period."

"That will provide the catalyst for a big move higher."

The number of reported global daily deaths from the novel coronavirus stood at the highest ever on Tuesday, according to a Reuters tally. Britain reported the highest number of deaths in Europe. shutdown worries, the STOXX 600 remains on track for its best month on record as investors bet on a global economic recovery, supported by trillions of dollars in stimulus and hopes of a vaccine.

M&A also drove big swings in stocks, with Britain's RSA Insurance RSA.L gaining 4.6% after it backed a 7.2 billion pound ($9.55 billion) cash offer from Canada's Intact Financial and Denmark's Tryg in one of Europe's biggest financial takeover bids this year. Boerse DB1Gn.DE rose 2.4% after the German stock exchange operator said it would acquire an 80% stake in corporate governance adviser Institutional Shareholder Services (ISS) for about $1.8 billion. decliners, German automotive supplier Schaeffler SHA_p.DE fell 5.3% after it set mid-term sales targets that disappointed investors. group Maersk MAERSKb.CO slipped 1.0% after it reported quarterly sales and operating profit in line with previous forecast and maintained its earnings forecast.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.